NO980529D0 - 1- 2-(2,3-dihydro-1H-inden-1-yl)etyl -4-(naftalen-1-yl)piperazinderivater, fremstilling derav og terapautisk anvendelse derav - Google Patents

1- 2-(2,3-dihydro-1H-inden-1-yl)etyl -4-(naftalen-1-yl)piperazinderivater, fremstilling derav og terapautisk anvendelse derav

Info

Publication number
NO980529D0
NO980529D0 NO980529A NO980529A NO980529D0 NO 980529 D0 NO980529 D0 NO 980529D0 NO 980529 A NO980529 A NO 980529A NO 980529 A NO980529 A NO 980529A NO 980529 D0 NO980529 D0 NO 980529D0
Authority
NO
Norway
Prior art keywords
inden
naphthalen
dihydro
ethyl
preparation
Prior art date
Application number
NO980529A
Other languages
English (en)
Other versions
NO980529L (no
Inventor
Pascal George
Mireille Sevrin
Philippe Manoury
Michel Peynot
Daniele De Peretti
Jean Francois Gibert
Arlette Tixidre
David Machnik
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO980529D0 publication Critical patent/NO980529D0/no
Publication of NO980529L publication Critical patent/NO980529L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Addiction (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
NO980529A 1995-08-09 1998-02-06 1- 2-(2,3-dihydro-1H-inden-1-yl)etyl -4-(naftalen-1-yl)piperazinderivater, fremstilling derav og terapautisk anvendelse derav NO980529L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9509684A FR2737724B1 (fr) 1995-08-09 1995-08-09 Derives de 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4- (naphtalen-1-yl) piperazine, leur preparation et leur application en therapeutique
PCT/FR1996/001216 WO1997006155A1 (fr) 1995-08-09 1996-08-01 Derives de 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4-(naphtalen-1-yl)piperazine, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
NO980529D0 true NO980529D0 (no) 1998-02-06
NO980529L NO980529L (no) 1998-04-14

Family

ID=9481836

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980529A NO980529L (no) 1995-08-09 1998-02-06 1- 2-(2,3-dihydro-1H-inden-1-yl)etyl -4-(naftalen-1-yl)piperazinderivater, fremstilling derav og terapautisk anvendelse derav

Country Status (20)

Country Link
US (1) US5929078A (no)
EP (1) EP0843670A1 (no)
JP (1) JP2000501699A (no)
KR (1) KR19990035954A (no)
CN (1) CN1199398A (no)
AR (1) AR003222A1 (no)
AU (1) AU707372B2 (no)
BR (1) BR9609977A (no)
CA (1) CA2228843A1 (no)
CO (1) CO4750833A1 (no)
CZ (1) CZ36898A3 (no)
FR (1) FR2737724B1 (no)
HU (1) HUP9802546A3 (no)
IL (1) IL123187A0 (no)
NO (1) NO980529L (no)
NZ (1) NZ315363A (no)
PL (1) PL324966A1 (no)
SK (1) SK16798A3 (no)
WO (1) WO1997006155A1 (no)
ZA (1) ZA966772B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI242011B (en) 1997-03-31 2005-10-21 Eisai Co Ltd 1,4-substituted cyclic amine derivatives
US8106074B2 (en) 2001-07-13 2012-01-31 Pierre Fabre Medicament Pyridin-2-yl-methylamine derivatives for treating opiate dependence

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE358300A (no) * 1928-04-28
US2927924A (en) * 1958-04-03 1960-03-08 Lilly Co Eli Novel phenethyl-substituted piperazines
NL132357C (no) * 1966-09-03
DE2037852C3 (de) * 1970-07-30 1980-06-26 Boehringer Sohn Ingelheim Neue Piperazinderivate und Verfahren zu ihrer Herstellung
CN1046507C (zh) * 1993-12-28 1999-11-17 法玛西雅厄普约翰美国公司 用于治疗中枢神经系统和心血管疾病的杂环化合物
FR2716193B1 (fr) * 1994-02-16 1996-04-05 Synthelabo Dérivés de 1[2-(1h-inden-3-yl)ethyl]-4-(naphtalen-1-yl)piperazine, leur préparation et leur application en thérapeutique.

Also Published As

Publication number Publication date
US5929078A (en) 1999-07-27
CN1199398A (zh) 1998-11-18
BR9609977A (pt) 1999-01-12
HUP9802546A2 (hu) 1999-02-01
JP2000501699A (ja) 2000-02-15
CO4750833A1 (es) 1999-03-31
CZ36898A3 (cs) 1998-05-13
WO1997006155A1 (fr) 1997-02-20
FR2737724A1 (fr) 1997-02-14
NO980529L (no) 1998-04-14
SK16798A3 (en) 1998-08-05
CA2228843A1 (en) 1997-02-20
AU6705396A (en) 1997-03-05
PL324966A1 (en) 1998-06-22
EP0843670A1 (fr) 1998-05-27
FR2737724B1 (fr) 1997-09-05
NZ315363A (en) 1998-10-28
MX9801057A (es) 1998-05-31
KR19990035954A (ko) 1999-05-25
AR003222A1 (es) 1998-07-08
ZA966772B (en) 1997-02-19
IL123187A0 (en) 1998-09-24
AU707372B2 (en) 1999-07-08
HUP9802546A3 (en) 1999-10-28

Similar Documents

Publication Publication Date Title
NO983286L (no) Kondenserte 1,2,4-tiadiazin- og kondenserte 1,4-tiazinderivater, deres fremstilling og anvendelse
DE69820214D1 (de) Verstellbare Fuss- und Sprunggelenkorthese
NO20000185D0 (no) Kondenserte 1,2,4-tiadiazinderivater, deres fremstilling og anvendelse
TR28448A (tr) Diz mafsali ortezi.
NO984107D0 (no) Kappa agnostiske forbindelser og farmasöytiske ormuleringer derav
NO954369L (no) Oksazolidindionderivater, deres fremstilling og anvendelse
NO975710D0 (no) Nye Dolastatinderivater, deres fremstilling og anvendelse
DK1019358T4 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
NO307092B1 (no) Sordaridin-derivater, anvendelse derav og farmasoeytisk blanding
NO20011157D0 (no) Benzenderivater og farmasøytisk anvendelse derav
IS4844A (is) Útskiptar 1,2,3,4-tetrahýdrónaftalenafleiður
NO20006460D0 (no) 4, 5, 6 og 7-Indol og indolinderivater, deres fremstilling og anvendelse
ATE266637T1 (de) 3,3-biarylpiperidin- und 3,3- biarylmorpholinderivate
DK0839146T3 (da) Piperazinderivater og deres anvendelse som 5-HT1A-antagonister
NO953673L (no) [1,2,4ÅTriazolo[4,3-aÅkinoksalinderivater, deres fremstilling og anvendelse
NO962477D0 (no) Benzamidderivater, deres fremstilling og deres terapautiske anvendelse
ITMI911470A0 (it) N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico
ITBO940427A0 (it) Articolazione d'anca per ortesi ortopedica.
NO980529D0 (no) 1- 2-(2,3-dihydro-1H-inden-1-yl)etyl -4-(naftalen-1-yl)piperazinderivater, fremstilling derav og terapautisk anvendelse derav
NO950560D0 (no) Piperazinderivater, deres fremstilling og terapautiske anvendelse
NO982549D0 (no) 5-naftalen-1-yl-1,3-dioksan-derivater, fremstilling og terapeutisk anvendelse derav
DE59506149D1 (de) Fussorthese
NO983492D0 (no) 2,3-disubstituerte cyklopentanderivater, fremgangsmÕte for fremstilling derav, og medisinsk anvendelse derav
IT8820113A0 (it) Derivati peptidici del3_aminodiidrotiofen_2_one, loro preparazione e impiego terapeutico.
NO985572L (no) Substituerte amidinobenzenderivater og medisinske preparater derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application